Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?

Clinical trial NCT06676384 · RECRUITING

Trial details

NCT number: NCT06676384
Sponsor: Christian Medical College, Vellore, India
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

IgA Nephropathy Renal Insufficiency, Chronic IgA Vasculitis IGA Glomerulonephritis

Start date: 2025-02-15
Primary completion: 2029-08-01
Enrollment: 585

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.